Latest news with #Silva
Yahoo
5 hours ago
- Business
- Yahoo
Why Marco Silva is becoming a strong candidate for Juventus head coach gig
Reports in Italy claim that Marco Silva's candidacy to take over as head coach of Juventus is growing ever stronger with each passing hour, as the Bianconeri look to appoint a new head coach after losing out on Antonio Conte. According to reports from Sky Sport Italia, Silva is now a 'strong' candidate to take over as head coach of Juventus after Igor Tudor, who will lead the Bianconeri into the FIFA Club World Cup which runs from mid-June to mid-July. Advertisement Juventus had been hoping to secure a return for Antonio Conte, who has ultimately decided to stay on with Napoli after winning the Scudetto in 2024-25. Gian Piero Gasperini, who Juve had also looked at, will leave Atalanta to join Roma. Cristiano Giuntoli during Igor Tudor's introductory press conference. (picture: The situation leaves the Old Lady looking at alternative candidates, with Silva, Roberto Mancini, Stefano Pioli and Bruno Genesio among them. Silva, however, is now being dubbed the frontrunner. Why Why Marco Silva is becoming a strong candidate for Juventus BRENTFORD, ENGLAND – MAY 18: Marco Silva, Manager of Fulham, celebrates victory at full-time following the Premier League match between Brentford FC and Fulham FC at Gtech Community Stadium on May 18, 2025 in Brentford, England. (Photo by) Silva has been a name Juventus have been studying for some time already. According to reports from Sky Sport Italia, sporting director Cristiano Giuntoli had been in contact with the coach's agent, Jorge Mendes, before learning of Conte's decision to stay on with Napoli. Advertisement While Giuntoli is also expected to leave Juventus this summer, the impending new Bianconeri executive Damien Comolli, is also keen on the idea of appointing Marco Silva as head coach. Comolli, who is expected to be officially announced as a new Juventus director next week, has recently reestablished contact with Jorge Mendes on behalf of the Bianconeri.
Cision Canada
8 hours ago
- Business
- Cision Canada
A Smokeless Canada is Within Reach -- Let's Talk Facts Français
MONTREAL, May 31, 2025 /CNW/ - On World No Tobacco Day, Imperial Tobacco Canada (Imperial) is calling on government, health advocates, and all Canadians to embrace harm reduction as a key strategy to achieve a smokeless Canada in the next decade. Despite years of public health efforts, approximately 11 percent of Canadian adults continue to smoke cigarettes — a figure that has remained relatively unchanged in recent years and which underscores the need to reevaluate the existing tobacco control approach and champion harm reduction as a key strategy to decrease smoking rates in Canada more quickly. At Imperial, the goal is clear: to help adults quit smoking or switch to less harmful alternatives. Similar to Health Canada's and Canadian health groups' goal of a Smoke Free Canada, Imperial is focused on reducing smoking rates to below 5% by 2035. But to do that adult smokers need a world where harm reduction is understood and supported. "For years, nicotine has been misunderstood, largely because its use was predominantly through the act of cigarette smoking." said Frank Silva, President and CEO of Imperial. "We need people to understand that nicotine, while addictive, does not cause cancer and is not the cause of smoking related diseases. By offering adult smokers access to less harmful alternatives that deliver nicotine without combustion, we can, in fact, significantly reduce the health impact on the Canadian Society." To that end, and to demonstrate our seriousness about reducing smoking in Canada, Imperial became the first company, in 2023, to launch a Health Canada approved nicotine replacement therapy (NRT) product in the form of a nicotine pouch, called ZONNIC, to help smokers quit. A product that shortly after its introduction, was pulled from shelves by an unprecedented Ministerial Order and put behind the counter at pharmacies. "Restricting access to a Health Canada approved cessation tool contradicts the fundamental principle of harm reduction," said Silva. "ZONNIC was licensed by Health Canada following a three-year approval process and is now held to stricter standards than all other similar NRTs like gums and lozenges. The evidence shows that if you want to help smokers quit, make cessation alternatives available where cigarettes are sold. The discrimination of the Ministerial Order has now created two major public health issues. It has reduced the amount of time pharmacists have to provide front-line care for all Canadians. It has created another flourishing illegal nicotine market in Canada, where unregulated and unsafe products are available with zero regulatory oversight and underage prevention. Both seriously undermining public health progress. On this World No Tobacco Day, Imperial is committed to unmask the myths and the rhetoric by focusing on the irrefutable weight of evidence from leading health organizations around the world. "The only way we can truly help adults quit, is by embracing harm reduction and making approved products such as ZONNIC available where smokers buy their cigarettes." Silva concluded. Countries such as the United Kingdom, Sweden, and Japan, that have embraced this opportunity and implemented supportive policies are now recording the lowest smoking rates in their history. Imperial supports efforts to ensure that safer choices are available to those who need them. A smokeless Canada is possible, but only if we embrace the full range of solutions available. About Imperial Tobacco Canada Imperial Tobacco Canada is the leading tobacco and nicotine company in Canada, part of the global BAT group. Our mission at BAT is to create A Better Tomorrow™ by promoting a Smokeless World. We envision a future where smokeless products replace cigarettes, encouraging smokers to make a Switch to Better. Imperial is committed to advancing THR through transparency, innovation, and collaboration. One such initiative is Omni™, a platform developed by our parent company BAT, to support education and stakeholder engagement around THR. Omni™ serves as a dynamic resource for those working toward a smoke-free future.
Yahoo
a day ago
- General
- Yahoo
Man convicted of attempting to kidnap, rape woman on Mass. walking path
A Fall River man has been convicted of attempting to rape a woman as she walked on a rail trail in Fall River on a summer morning three years ago, prosecutors said. Paulo Silva, 28, of Fall River, was found guilty by a Bristol Superior Court jury on Thursday of assault with intent to rape, attempted kidnapping and related charges, according to Bristol District Attorney Thomas Quinn III. A woman, then 52, said Silva accosted and attempted to sexually assault her on the Quequechan Rail Trail in Fall River on July 18, 2022. Fall River Police were called to the path around 7 that morning, where the woman said she had noticed Silva interacting with a pregnant woman. As she walked past the pair, Silva began to follow the woman, she said. He grabbed her arm and began to push her off the trail and toward a grassy embankment of the Quequechan River, while 'verbally indicating he was going to sexually assault her,' according to prosecutors. The woman screamed for help, and Silva ran away as two people nearby rushed to the commotion. Fall River detectives viewed surveillance video showing Silva entering his car at the trailhead soon after the incident. He later told the investigators he had tried to obtain the phone number of a woman walking on the trail. Silva admitted to grabbing the victim as she strode past and pulling her toward the embankment. He indicated to police that he planned to sexually assault the woman, but released her and ran when she called for help, prosecutors said. 'It is extremely concerning that a woman can't even enjoy a morning walk without being attacked,' Quinn said in a statement. 'The defendant also approached and harassed a pregnant woman before trying to rape the victim. The defendant poses a clear danger to the public and does not belong on the street.' Silva was sentenced Friday to between four-and-a-half and five-and-a-half years in state prison, followed by two years of probation, according to Quinn's office. The sentence was shorter than the one sought by assistant district attorneys Kalene Kobza and Gillian Kirsch, who prosecuted the case and requested that Silva be locked up for seven to 12 years. Boston Mayor Wu lays out safety plan as city enters volatile summer months Man stole police officer's gun, fired it outside Mass General Hospital, officials say Boston Police responding to 'active incident' near Mass General Hospital After serious safety concerns at Boston Calling last year, fans return in 2025 Read the original article on MassLive.
Newsweek
a day ago
- Business
- Newsweek
ChatGPT Asked If Boomers Are Right About Millennials—It Doesn't Hold Back
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Two millennial moms who felt tired of the negative tropes about their generation decided to take matters into their own hands by asking ChatGPT what it thinks—and the responses did not disappoint. Like many other millennials (people born between 1981 and 1996), entrepreneurs Miranda Hann and Lexi Silva came of age during a time of economic and political uncertainty, and it's taking its toll. Indeed, Hann, 33, of Florida, believes that systematic failures have left her generation struggling to afford what were once considered necessities. She told Newsweek that millennials were "promised the world and left wanting." Over time, the two moms have become increasingly exhausted by older generations hating on millennials. They've put up with the negative stereotypes about millennials supposedly being lazy, entitled, and bad with money, but now the duo has finally had enough. They decided to ask ChatGPT, the generative artificial intelligence chatbot developed by OpenAI, whether it thinks millennials are as lazy as baby boomers (people born between 1946 and 1964) think. The instruction sent to OpenAI's chatbot, ChatGPT, asking it to analyze baby boomers and millennials. The instruction sent to OpenAI's chatbot, ChatGPT, asking it to analyze baby boomers and millennials. @_simplifiedsocial / Instagram "We decided to ask ChatGPT about millennials and if we were set up for failure because we know so many people who are equally frustrated and sick of the system," Hann said. She continued: "ChatGPT analyzed and confirmed that millennials have little to no support, are making less money but spending more to afford the same standard of living boomers afforded with half the salary and confirmed that boomers are completely out of touch with reality." There were several explanations provided by ChatGPT, including that boomers were "born into the golden cheat code" because a single income used to buy a house and the job market was more stable back then, that boomers "broke the ladder behind them" by deregulating the housing market and burdening people with student debt, and that they got "financially fat and morally fragile." Newsweek has contacted OpenAI via email for comment. Hann and Silva, also 33, couldn't have agreed more with what the AI chatbot had to say. In their initial instruction, they asked ChatGPT for unvarnished honesty because they feel "tired of their gaslighting." Well, ChatGPT really didn't hold back. The responses were provided in a sassy and human-like tone, which Silva explains is because they have spent over a year training ChatGPT to use their "tone and brand voice." Silva told Newsweek: "We weren't shocked at Chat's sass because we trained her that way. Our favorite line she came up with was, 'you built the bridge then made us pay the toll, Frank.'" They shared the response in a video on social media (@_simplifiedsocial) and the clip went viral with over 3.7 million views and more than 181,000 likes at the time of writing. There were of course plenty of boomers who weren't too happy with their portrayal, but Silva said that many millennials felt validated by the video. They have connected with countless people who feel that the system is dooming them to failure, so Hann and Silva wanted to speak out. "The American dream of a white picket fence, car, affordable living, and two kids isn't realistic or attainable anymore," Silva said. "Families used to survive on one salary and live comfortable middle-class lives. But now, parents work full-time or have multiple jobs, kids go to daycares (which cost a kidney), mortgages are an entire paycheck. We're all just trying to survive—there's no thriving anymore." Since the video went viral on Instagram, it has amassed over 3,200 comments already. One comment reads: "ChatGPT will always be that girl." Another Instagram user wrote: "Dang, ChatGPT left no crumbs *mic drop*." While another person added: "Well said. Sidenote: ChatGPT definitely identifies as a millennial." Do you have any viral videos or pictures that you want to share? We want to see the best ones! Send them in to life@ and they could appear on our site.
Medscape
a day ago
- General
- Medscape
How Lifestyle Changes Can Make a Difference in PsA
Psoriatic arthritis (PsA), a chronic inflammatory condition characterized by dactylitis, enthesitis, peripheral arthritis, skin and nail psoriasis, and spondylitis, occurs in around 10%-30% of people with psoriasis. While several pharmacological treatment strategies exist, PsA continues to significantly impact patients' pain levels, functional capacity, and mental well-being. Along with joint and skin manifestations, PsA is associated with several comorbidities, including cardiovascular disease (CVD), central sensitization syndrome, diabetes mellitus, dyslipidemia, fatty liver disease, gout, infections, inflammatory bowel disease, kidney disease, metabolic syndrome, obesity, osteoporosis, and uveitis, all of which negatively impact quality of life (QOL). Patients with PsA are also more likely to experience psychological issues, such as anxiety and depression. Given these challenges, nonpharmacological interventions play a key role in disease management. Healthy lifestyle changes, including dietary modifications, regular exercise, and quitting smoking — along with psychological interventions — are essential to improve PsA and QOL. Here are common nonpharmacological interventions that can improve symptoms and QOL of patients with PsA. In their treatment guideline, the American College of Rheumatology and National Psoriasis Foundation (ACR/NPF) recommend nonpharmacological interventions for PsA, including acupuncture, low-impact exercise, massage, occupational therapy, physical therapy, smoking cessation, and weight loss despite weak evidence for all except smoking cessation. The Importance of Physical Activity in Reducing Inflammation Physical activity and targeted exercises play an important role in reducing inflammation, disease severity, and outcomes in patients with PsA. Studies have found that exercise, particularly when combined with dietary modifications, can improve PsA symptoms. The ACR/NPF recommend low-impact exercise over high-impact exercise for managing PsA. In their guideline, the European Alliance of Associations for Rheumatology notes regular physical activity as an integral part of care for patients with PsA. Regular exercise, including resistance training, aerobic, and flexibility exercises may improve and preserve joint function, reduce inflammation, and enhance QOL in patients with PsA. A 12-week single-blind parallel randomized controlled trial by Silva et al found functional training and resistance training similarly improved disease activity, functional capacity, functional status, general QOL, and muscle strength in patients with PsA. The Link Between Diet and Inflammation in PsA Dietary interventions focused on weight loss alleviate mechanical strain on the joints and reduce the risk of CVD in patients with PsA. Weight loss has also been shown to improve disease activity. Moreover, research suggests some dietary modifications, along with exercise, can improve PsA disease outcomes independent of weight loss. Diets rich in saturated fats or certain omega-6 fatty acids while anti-inflammatory diets can improve PsA symptoms and disease activity. Among various anti-inflammatory diets, the Mediterranean diet has gained the most popularity as studies have found it to be associated with lower disease activity in patients with PsA. According to the Medical Board of the National Psoriasis Foundation, patients with PsA may consider the Mediterranean diet on a trial basis in conjunction with pharmacotherapy. The NPF medical board also emphasizes increased intake of fiber, complex carbohydrates, monosaturated fatty acids, and omega-3 fatty acids. Although other dietary interventions for improving PsA are less studied, a case report by Lewandowska et al found a whole-food vegan diet improved PsA symptoms a 40-year-old woman. Further research, however, is needed to confirm the role of vegetarian or vegan diets in modulating PsA disease activity. Smoking: What Role Does It Play? The association between smoking and the development of PsA remains inconclusive, with studies yielding mixed results. At the population level, smoking is positively associated with PsA. However, some studies suggest smoking increases the risk of developing PsA, while others indicate no significant association between cigarette smoking and the progression of joint damage. Beyond disease onset, smoking has been linked to poorer treatment outcomes in PsA. An observational cohort study by Højgaard et al found that patients with PsA who smoke had poor responses to treatment with tumor necrosis factor-α inhibitors and were also less likely to adhere to their treatment plan. Additionally, smoking is a risk factor for CVD and other comorbidities common in PsA. Therefore, smoking cessation is an important lifestyle intervention for patients with PsA — not only to improve treatment efficacy but also to reduce the risk of other comorbidities, thereby improving the QOL. Integrating Weight Management in PsA Care The relationship between PsA and obesity appears to be bidirectional: Research has shown obesity is a common risk factor for developing PsA and that joint dysfunction and reduced physical activity due to PsA itself may result in weight gain. Patients with PsA and obesity often exhibit higher disease activity and poor response to treatment. An interventional study by Klingberg et al showed weight loss treatment with a very low energy diet improved disease activity, pain, fatigue, and C-reactive protein in patients with PsA and obesity. Similarly, another study by Klingberg et al also reported improvement in PsA disease activity after 12 months of weight loss treatment. In addition to diet and exercise, GLP-1 and glucose-dependent insulinotropic polypeptide receptor agonists and incretins associated with weight loss may benefit patients with PsA and obesity. However, research on the effect of such drugs on PsA is quite limited still and requires further investigation. The Bidirectional Link Between Sleep and Inflammation In addition to obesity, there also appears to be a bidirectional relationship between PsA and sleep disorders. Persistent sleep disorders in PsA may be interconnected with inflammatory disease activity, chronic pain, fatigue, and psychological distress, creating a vicious cycle where each factor intensifies the others. Prolonged and significant decline in sleep quality reduces overall QOL and increases a patient's risk of developing CVD, hypertension, and metabolic disorders, comorbid conditions associated with PsA. Prolonged deterioration of sleep quality can negatively impact the QOL of PsA patients and increase the risk of developing hypertension, CVD, and metabolic disorders. Several lifestyle changes can help to improve sleep quality in patients with PsA. These include maintaining regular sleep-wake cycles, limiting alcohol and caffeine intake, and improving the patient's sleeping environment. Additionally, medications used to treat PsA — such as guselkumab, tumor necrosis factor inhibitors (adalimumab, certolizumab pegol, etanercept, golimumab, infliximab), and the Janus kinase inhibitor filgotinib — have shown potential in improving sleep outcomes in patients with PsA. The Psychological Burden of PsA Pain, fatigue, anxiety, and depression are common psychological comorbidities of PsA that have a negative impact on QOL. The odds of being diagnosed with behavioral and mental health disorders are higher in patients with PsA compared to the general population. Even with treatment, studies have shown that PsA affects patients emotionally, socially, and occupationally, underscoring the importance of comprehensive management since targeting the inflammatory activity of PsA alone may not improve the QOL. Cognitive behavioral therapy is a well-established psychological intervention that can improve symptoms of depression, anxiety, and sleep disturbances in patients with PsA. It can also improve sleep quality in PsA patients. Although research is limited, the effectiveness of cognitive behavioral therapy (CBT) to improve psychological distress may in turn improve overall QOL in patients with PsA. Although research on this is limited, CBT can prove to be beneficial in improving mood disorders and the overall QOL of PsA patients.
